LY06006
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY06006, covering 2021-09-29 to 2021-09-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for Fracture [Phase 3]